
Pre-exposure prophylaxis, or PrEP, is a daily pill regimen that has been proven to prevent HIV infection. In 2021, the US government issued guidelines mandating that most private health plans and Medicaid expansion plans cover PrEP at zero cost to patients. However, some patients continue to face issues with insurance coverage for PrEP, including erroneous billing and high costs. This has led to concerns and complaints from patients, with HIV advocates calling for better enforcement of the guidelines. While there have been some victories in ensuring PrEP coverage, the current system has been described as problematic, highlighting the need for penalties for non-compliance.
| Characteristics | Values |
|---|---|
| Cost of PrEP | Generic: $60/month |
| Branded: $2,000/month | |
| Cost covered by insurance | Yes |
| Cost covered by insurance in all states | No |
| Cost covered by insurance for all plans | No |
| PrEP coverage by insurance | Must be covered at zero cost to patients |
| PrEP coverage by insurance from | July 2021 |
| PrEP coverage by insurance mandated by | Department of Labor |
| PrEP coverage by insurance mandated for | Most private health plans and Medicaid expansion plans |
Explore related products
What You'll Learn

PrEP is an HIV prevention tool
Pre-exposure prophylaxis, or PrEP, is a daily pill that has been shown to prevent HIV infection. It is a powerful tool that, when taken correctly, can lower the risk of infection from sex by more than 90%. PrEP is especially important for people who are at high risk of contracting HIV, such as those who are sexually active and not consistently using condoms, or those who have an HIV-positive partner.
In the United States, PrEP is supposed to be available at no cost to patients, as it has been rated as an effective preventive service. Under the Affordable Care Act and guidelines issued by the US government in 2021, most private health plans and Medicaid expansion plans are required to cover the costs of PrEP. This includes the cost of prescription drugs, laboratory tests, and medical appointments related to PrEP.
Despite these provisions, some patients have reported facing issues with insurance coverage for PrEP. In some cases, patients have received erroneous bills for ancillary medical services or have been charged for PrEP-related lab tests and doctor's visits. These costs can be significant, with a monthly supply of generic PrEP costing around $60, while brand-name drugs can cost up to $2,000.
To address these issues, the Department of Labor has clarified the rules, stating that health plans must cover the costs of PrEP-related services with zero-cost co-pays, co-insurance, or deductibles. However, enforcement of these rules relies heavily on patient complaints, and there are currently no penalties for non-compliance. As a result, HIV organizations and lawyers specializing in HIV policy are working to advocate for broader enforcement and ensure that patients have access to PrEP without financial barriers.
Reducing Medical Bills: Keeping Insurance Deductibles Intact
You may want to see also
Explore related products

US health insurers must cover PrEP costs
In 2019, the US Preventive Services Task Force gave PrEP a Grade A recommendation, meaning that insurers are obligated to cover the medication at no cost to their policyholders. This is due to provisions in the Affordable Care Act, which state that health insurers must cover the costs of preventative services that are rated "A" or "B" by the task force. The task force is made up of an independent panel of clinicians and scientists, who concluded that PrEP is of ""substantial benefit in decreasing the risk of HIV infection".
Following this recommendation, the Department of Labor issued rules in July 2021 clarifying that health plans need to cover the costs of prescription drugs proven to prevent HIV infection, along with related lab tests and medical appointments, at no cost to patients. This includes HIV-prevention medications like Gilead Sciences' Truvada, which can cost up to $2,000 a month without insurance.
Despite these rulings, some patients continue to face issues with insurance companies billing them for PrEP-related costs. In California, Washington, Texas, Ohio, Georgia, and Florida, HIV advocates and clinic workers report that patients are confused by formularies that obfuscate drug costs and receive erroneous bills for ancillary medical services. Enforcement of these rules is largely driven by patient complaints, and there is currently a lack of penalties for noncompliance. However, HIV organizations are pushing for broader enforcement and celebrating small victories, such as when the Texas Department of Insurance informed Blue Cross and Blue Shield of Texas that they had reprocessed a patient's claims for PrEP-related lab costs.
Commercial Insurance Medical: Understanding the Basics
You may want to see also
Explore related products

Issues with insurance companies billing for PrEP
Although HIV preventive care is supposed to be free in the US, some patients are still paying for it. Under the Affordable Care Act, health insurers are required to cover the costs of PrEP as it is rated as an effective preventive service. Despite this, patients are still facing roadblocks to free PrEP, including being charged co-pays when picking up the medication and receiving bills for doctor's visits during which PrEP was prescribed.
Some health insurers have blamed coverage issues on providers and pharmacies submitting incorrect billing codes, rather than a refusal to cover treatment. However, LGBTQ+ health providers say they often have to fight with insurance companies to prevent their patients from paying bills. This has resulted in patients filing lawsuits against their insurance companies, such as the class-action lawsuit filed by Luke Troxel against UMR, which administers his employer insurance plan.
The Department of Labor has clarified that health plans need to cover the costs of prescription drugs proven to prevent HIV infection, along with related lab tests and medical appointments, at no cost to patients. However, this ruling has not been effectively enforced, and patients are still facing issues with insurance companies billing for PrEP. Enforcement is largely driven by patient complaints, and there are currently no penalties for noncompliance.
The mandate also does not cover all formulations of PrEP, leaving individuals with denials and bills for more expensive formulations. This lack of coverage often comes in the form of a denial or an unexpected bill, and providers and pharmacists are not always informed about which drug will be covered until a prescription is ordered. As a result, patients are left with the burden of high out-of-pocket expenses, which can be a significant barrier to accessing PrEP, especially for those who cannot afford the costs.
Combining Medicaid and Insurance: Is It Possible?
You may want to see also
Explore related products

HIV prevention care is supposed to be free in the US
Despite this, some patients are still facing erroneous bills for PrEP-related services. In some cases, insurance companies are charging patients hundreds of dollars for lab tests and doctor's visits related to their PrEP prescription. This is despite the Department of Labor's clarification in July 2021 that these services should be covered at no cost to patients.
The issue of erroneous billing for PrEP-related services has been reported in several states, including California, Washington, Texas, Ohio, Georgia, and Florida. HIV advocates and clinic workers in these states say that patients are confused by formularies that obfuscate drug costs and by bills for ancillary medical services. The costs of PrEP can be significant, with a monthly supply ranging from $60 for a generic version to up to $2,000 for brand-name drugs.
The problem of high costs and limited access to PrEP is particularly acute for Black and Hispanic patients, who have lower rates of PrEP usage despite being at higher risk of HIV infection. Women have also been largely ignored by PrEP marketing efforts, according to Dr. Rachel Scott, scientific director of women's health research at the MedStar Health Research Institute in Washington, DC.
While HIV organizations push for broader enforcement of the Affordable Care Act's provisions on PrEP coverage, there have been some small victories. For example, in February 2022, Anthony Cantu received a letter from the Texas Department of Insurance informing him that his insurance company had reprocessed his claims for PrEP-related lab costs.
Medical Insurance Companies and Their 1099 Forms
You may want to see also
Explore related products

Private health plans must cover PrEP at zero cost
In 2019, the U.S. Preventive Services Task Force gave PrEP a grade A recommendation, which means that private health insurers are now obligated to cover the medication at no cost to their policyholders. This recommendation was based on the finding that PrEP is of "substantial benefit in decreasing the risk of HIV infection." The task force also proposed regular HIV screening for pregnant women and individuals aged 15 to 65 years.
Under the Affordable Care Act, health insurance plans are required to cover preventive services that have been given an "A" or "B" rating by the task force. This act also triggered rules requiring health insurers to cover the costs associated with PrEP, including prescription drugs, doctor appointments, and lab tests. Insurers were given until January 2021 to adhere to this ruling.
Despite these rulings, some patients have continued to receive bills for PrEP-related services. In some cases, patients have been confounded by formularies that obfuscate drug costs and by erroneous bills for ancillary medical services. The costs of PrEP can be significant, with a monthly supply ranging from $60 for a generic drug to up to $2,000 for brand-name drugs like Truvada and Descovy.
To address this issue, the Department of Labor issued rules in July 2021 clarifying that health plans need to cover the costs of prescription drugs proven to prevent HIV infection, along with related lab tests and medical appointments, at no cost to patients. However, erroneous billing continues to be a problem, and enforcement of these rules is driven largely by patient complaints. Patients who have concerns about their plan's compliance with the requirements should contact the Department of Labor's Employee Benefits Security Administration.
It is important to note that the availability of PrEP at no cost to patients is a critical step in preventing HIV infection. PrEP has been shown to reduce the risk of infection by up to 92% in people who are at high risk and take the drug consistently. This development aligns with President Donald Trump's pledge to end the HIV epidemic in the United States by 2030.
Emergency Medical Insurance: California's Options in a Crisis
You may want to see also
Frequently asked questions
PrEP stands for pre-exposure prophylaxis. It is an approach to preventing HIV infection.
Yes, medical insurance covers PrEP. In 2021, the US government issued guidelines that most private health plans and Medicaid expansion plans must cover PrEP. This means that patients are required to pay zero co-pays, co-insurance, or deductibles.
Enforcement of these guidelines is driven largely by patient complaints. If you have concerns about your plan's compliance with the requirements, you should contact the Department of Labor's Employee Benefits Security Administration.
The cost of PrEP without insurance is $60 for a monthly supply of generics and up to $2,000 for brand-name drugs.

































![PREP: Derma Protective Cream, Paraben Free 2.53 Fluid Ounce (75ml) Jar [ Italian Import ]](https://m.media-amazon.com/images/I/817j35+tVuL._AC_UY218_.jpg)









